6/23/2010

Hospira obtained FDA approval to launch injectable antibiotic meropenem in 500-milligram and 1-gram vials. Meropenem, a copy of AstraZeneca's Merrem I.V., is the first generic carbapenem antibiotic approved in the country, said Thomas Moore, president of Hospira's U.S. operations.

Related Summaries